Peptide Compound Database

20 compounds researched, rated, and cited. Every entry includes evidence quality ratings, FDA regulatory status, key studies, and safety information.

All (20)🩹 Healing & Recovery (3)⚖️ Weight Loss (4)📈 Growth Hormone (5)🧠 Nootropic & Cognitive (2)❤️ Sexual Health (2) Longevity & Anti-Aging (8) Skin & Hair (2)🛡️ Immune Support (3)🫁 Gut Health (1)🔥 Metabolic (6)
Healing & RecoveryL2

BPC-157Body Protection Compound-157, Bepecin

128studies

A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.

Preliminary EvidenceBanned from Compounding (Category 2)WADA bannedAngiogenesis & VEGF Modulation
Weight LossL5

SemaglutideOzempic, Wegovy

630studies

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.

Strong EvidenceFDA ApprovedGLP-1 Receptor Agonism
Weight LossL5

TirzepatideMounjaro, Zepbound

180studies

An FDA-approved dual GIP/GLP-1 receptor agonist that has shown the highest weight loss results of any approved medication.

Strong EvidenceFDA ApprovedDual GIP/GLP-1 Agonism
Healing & RecoveryL3

TB-500Thymosin Beta-4, TB4

119studies

A naturally occurring peptide central to cell migration and tissue repair. Phase 2 human wound healing trials showed accelerated healing; also studied for cardiac and corneal repair.

Moderate EvidenceBanned from Compounding (Category 2)WADA bannedActin Sequestration & Cell Migration
Growth HormoneL3

CJC-1295CJC-1295 DAC, CJC-1295 without DAC

24studies

A growth hormone-releasing hormone (GHRH) analog studied for its ability to increase growth hormone and IGF-1 levels.

Moderate EvidenceBanned from Compounding (Category 2)WADA bannedGHRH Receptor Agonism
Growth HormoneL3

IpamorelinNNC 26-0161

33studies

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

Moderate EvidenceBanned from Compounding (Category 2)WADA bannedGhrelin Receptor Agonism
Skin & HairL3

GHK-CuCopper Peptide, Glycyl-L-histidyl-L-lysine:copper(II)

96studies

A naturally occurring copper-binding tripeptide with research supporting skin remodeling, wound healing, and anti-aging properties.

Moderate EvidenceResearch OnlyCopper-Dependent Gene Modulation
Sexual HealthL5

PT-141Bremelanotide, Vyleesi

56studies

An FDA-approved melanocortin receptor agonist used for hypoactive sexual desire disorder in premenopausal women.

Strong EvidenceFDA ApprovedMelanocortin MC4R Agonism
Growth HormoneL4

SermorelinGeref, GHRH(1-29)NH2

51studies

A growth hormone-releasing hormone analog with a long history of clinical use for GH deficiency diagnosis and therapy.

Moderate EvidenceFDA ApprovedWADA bannedGHRH Receptor Agonism
Growth HormoneL5

TesamorelinEgrifta, TH9507

36studies

An FDA-approved GHRH analog used for HIV-associated lipodystrophy, with research into broader metabolic and cognitive applications.

Strong EvidenceFDA ApprovedWADA bannedGHRH Receptor Agonism
Weight LossL2

AOD-9604Advanced Obesity Drug 9604, Anti-Obesity Drug 9604

23studies

A modified fragment of human growth hormone studied for fat metabolism without the growth-promoting effects of full GH.

Preliminary EvidenceResearch OnlyWADA bannedLipolytic GH Fragment Activity
Longevity & Anti-AgingL2

EpithalonEpitalon, Epithalone

33studies

A tetrapeptide studied for its potential to activate telomerase and extend cellular lifespan, primarily in Russian research.

Preliminary EvidenceResearch OnlyTelomerase Activation
Nootropic & CognitiveL3

SelankTP-7

54studies

A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.

Moderate EvidenceResearch OnlyTuftsin Analog / Immune-Neuro Modulation
Nootropic & CognitiveL3

SemaxMEHFPGP, Heptapeptide ACTH analog

84studies

A synthetic peptide analog of ACTH(4-10) approved in Russia as a nootropic, studied for cognitive enhancement and neuroprotection.

Moderate EvidenceResearch OnlyMelanocortin & BDNF Signaling
Weight LossL4

RetatrutideLY3437943, Triple Agonist

31studies

A triple-acting GIP/GLP-1/glucagon receptor agonist in Phase 3 trials showing potentially the highest weight loss of any drug in development.

Moderate EvidenceIn Clinical TrialsTriple GIP/GLP-1/Glucagon Agonism
MetabolicL2

MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-c

43studies

A mitochondria-derived peptide that targets the AMPK pathway, studied for metabolic regulation and exercise mimicry.

Preliminary EvidenceResearch OnlyWADA bannedMitochondrial-Derived AMPK Activation
Skin & HairL3

Melanotan IIMT-2, MT-II

59studies

A melanocortin receptor agonist that stimulates melanin production (tanning) and has sexual function effects. Significant safety concerns.

Moderate EvidenceResearch OnlyNon-Selective Melanocortin Agonism
Growth HormoneL4

MK-677Ibutamoren, Nutrobal

75studies

An oral ghrelin mimetic (not a peptide) that stimulates growth hormone release. Has extensive human data but has not achieved FDA approval.

Moderate EvidenceResearch OnlyWADA bannedOral Ghrelin Receptor Agonism
Longevity & Anti-AgingL3

NAD+Nicotinamide Adenine Dinucleotide, NAD

260studies

A coenzyme critical for cellular energy and DNA repair. Not technically a peptide, but commonly discussed alongside peptide therapies in the longevity space.

Moderate EvidenceResearch OnlySirtuin & PARP Cofactor
Immune SupportL4

Thymosin Alpha-1Tα1, Thymalfasin

113studies

A naturally occurring thymic peptide approved internationally for immune modulation, with extensive clinical data in hepatitis and cancer immunotherapy.

Strong EvidenceResearch OnlyDendritic Cell & T-Cell Activation